We studied the cytotoxicity of acadesine (5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside) for tumor and normal cells of various species and tissue origin. In tumor cells, acadesine triggered non-apoptotic death; the potency of the compound to normal cells was substantially lower. Acadesine was toxic for tumor cells with multidrug resistant phenotypes caused by the transmembrane transporter Р-glycoprotein or lack of proapoptotic p53. Activity of adenosine receptors was required for acadesine-induced cell death, whereas functioning of АМР-dependent protein kinase was not required. A more pronounced cytotoxicity for tumor cells, as well as the non-canonical death mechanism(s), makes acadesine a promising candidate for antitumor therapy.
// Acadesine. AICA Riboside, ARA 100, Arasine, GP 1 110 // Drugs R D 2008, V.9, №3, P.169-175
Jose C., Bellance N., Chatelain EH., Benard G., Nouette-Gaulain K., Rossignol R. // Drugs R D 2012, V.12, P.100-109
Jose C., Hébert-Chatelain E., Bellance N., Larendra A., Su M., Nouette-Gaulain K., Rossignol R. // Biochimica et Biophysica Acta . 2011, №1807, P.707-718
Van Den Neste E., Van Den Berghe G., Bontemps F. // Expert Opin. Investig. Drugs. 2010, V.19, №4, P.571-578
Javaux F., Vincent MF., Wagner DR., Van den Berghe G. // Biochem. J. 1995, V.305, P.913-919